Free Trial
→ Altucher: Turn $900 into $108,000 in just 12 months? (From Paradigm Press) (Ad) Buy MVSTW Stock  Free MVSTW Stock Alerts

Microvast (MVSTW) Financials

$0.19 -0.02 (-7.53%)
As of 05/2/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Microvast

Annual Income Statements for Microvast

This table shows Microvast's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -158 -106 -195
Consolidated Net Income / (Loss)		 -158 -106 -195
Net Income / (Loss) Continuing Operations		 -158 -106 -195
Total Pre-Tax Income 		-158 -106 -195
Total Revenue		 204 308 380
Net Interest Income / (Expense)		 -0.14 0.98 -8.97
Total Interest Income		 3.18 3.61 0.74
Investment Securities Interest Income		 3.18 3.61 0.74
Total Interest Expense		 3.32 2.63 9.71
Long-Term Debt Interest Expense		 3.32 2.63 9.71
Total Non-Interest Income		 204 307 389
Net Realized & Unrealized Capital Gains on Investments		 0.00 0.00 9.41
Other Non-Interest Income		 204 307 380
Total Non-Interest Expense		 363 413 576
Marketing Expense		 66 69 64
Other Operating Expenses		 298 346 342
Impairment Charge		 1.80 0.50 93
Other Special Charges		 -2.65 -2.01 77
Income Tax Expense		 0.03 0.01 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 -0.08 0.00
Basic Earnings per Share		 ($0.52) ($0.34) ($0.61)
Weighted Average Basic Shares Outstanding		 303.28M 310.91M 318.46M
Diluted Earnings per Share		 ($0.52) ($0.34) ($0.61)
Weighted Average Diluted Shares Outstanding		 303.28M 310.91M 318.46M
Weighted Average Basic & Diluted Shares Outstanding		 309.41M 317.21M 325.21M

Quarterly Income Statements for Microvast

This table shows Microvast's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -37 -34 -30 -26 -26 -25 -25 -102 13 -82
Consolidated Net Income / (Loss)		 -37 -34 -30 -26 -26 -25 -25 -102 13 -82
Net Income / (Loss) Continuing Operations		 -37 -34 -30 -26 -26 -25 -25 -102 13 -82
Total Pre-Tax Income 		-37 -34 -30 -26 -26 -25 -25 -102 13 -82
Total Revenue		 39 66 48 76 80 104 80 82 97 121
Net Interest Income / (Expense)		 0.10 0.72 0.92 1.03 0.09 -1.06 -1.61 -1.85 -4.10 -1.40
Total Interest Income		 0.87 1.58 1.38 1.52 0.58 0.13 0.12 0.25 0.19 0.19
Investment Securities Interest Income		 0.87 1.58 1.38 1.52 0.58 0.13 0.12 0.25 0.19 0.19
Total Interest Expense		 0.77 0.86 0.46 0.49 0.49 1.19 1.73 2.09 4.29 1.60
Long-Term Debt Interest Expense		 0.77 0.86 0.46 0.49 0.49 1.19 1.73 2.09 4.29 1.60
Total Non-Interest Income		 39 65 47 75 80 105 81 84 101 123
Other Non-Interest Income		 39 65 47 75 80 105 81 84 101 113
Total Non-Interest Expense		 75 100 77 102 106 127 105 183 84 204
Marketing Expense		 17 16 16 15 19 18 17 15 16 16
Other Operating Expenses		 59 82 63 87 87 109 88 80 80 94
Other Special Charges		 -0.97 0.26 -0.88 -0.39 -0.53 -0.21 -0.44 0.23 -11 89
Basic Earnings per Share		 ($0.12) ($0.10) ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.04 ($0.25)
Weighted Average Basic Shares Outstanding		 305.98M 303.28M 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 320.55M 318.46M
Diluted Earnings per Share		 ($0.12) ($0.10) ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.03 ($0.24)
Weighted Average Diluted Shares Outstanding		 305.98M 303.28M 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 367.03M 318.46M
Weighted Average Basic & Diluted Shares Outstanding		 309.29M 309.41M 309.43M 316.31M 316.53M 317.21M 317.20M 323.82M 323.82M 325.21M

Annual Cash Flow Statements for Microvast

This table details how cash moves in and out of Microvast's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -233 -214 21
Net Cash From Operating Activities		 -54 -75 2.81
Net Cash From Continuing Operating Activities		 -54 -75 2.81
Net Income / (Loss) Continuing Operations		 -158 -106 -195
Consolidated Net Income / (Loss)		 -158 -106 -195
Provision For Loan Losses		 1.64 0.24 3.74
Depreciation Expense		 20 22 30
Amortization Expense		 0.55 0.79 0.78
Non-Cash Adjustments to Reconcile Net Income		 113 86 216
Changes in Operating Assets and Liabilities, net		 -30 -78 -53
Net Cash From Investing Activities		 -176 -166 -12
Net Cash From Continuing Investing Activities		 -176 -166 -12
Purchase of Property, Leasehold Improvements and Equipment		 -151 -187 -28
Purchase of Investment Securities		 -25 -5.97 0.00
Sale of Property, Leasehold Improvements and Equipment		 0.01 1.65 10
Sale and/or Maturity of Investments		 0.00 26 5.56
Net Cash From Financing Activities		 4.97 33 38
Net Cash From Continuing Financing Activities		 4.97 33 38
Issuance of Debt		 59 48 127
Repayment of Debt		 -54 -15 -67
Other Financing Activities, Net		 0.00 0.00 -22
Effect of Exchange Rate Changes		 -8.59 -6.56 -6.84
Cash Interest Paid		 5.14 4.37 7.44
Cash Income Taxes Paid		 0.00 0.00 0.00

Quarterly Cash Flow Statements for Microvast

This table details how cash moves in and out of Microvast's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 19 -113 -42 -90 -81 -1.02 -1.49 18 10 -5.37
Net Cash From Operating Activities		 4.94 4.67 -11 -30 -29 -4.95 2.03 0.11 -5.43 6.10
Net Cash From Continuing Operating Activities		 4.94 4.67 -11 -30 -29 -4.95 2.03 0.11 -5.43 6.10
Net Income / (Loss) Continuing Operations		 -37 -34 -30 -26 -26 -25 -25 -102 -9.87 -82
Consolidated Net Income / (Loss)		 -37 -34 -30 -26 -26 -25 -25 -102 -9.87 -82
Provision For Loan Losses		 1.19 -1.85 -1.09 0.26 -0.21 1.27 0.58 0.18 -0.99 3.98
Depreciation Expense		 4.78 4.65 4.89 4.91 4.85 7.50 7.47 7.44 7.53 7.62
Amortization Expense		 0.14 0.13 0.21 0.19 0.19 0.19 0.19 0.19 0.19 0.19
Non-Cash Adjustments to Reconcile Net Income		 23 29 22 23 21 21 16 108 35 81
Changes in Operating Assets and Liabilities, net		 13 6.20 -7.52 -32 -29 -11 2.89 -14 -37 -4.29
Net Cash From Investing Activities		 -17 -91 -36 -58 -60 -12 -4.53 -2.92 -4.53 -0.18
Net Cash From Continuing Investing Activities		 -17 -91 -36 -58 -60 -12 -4.53 -2.92 -4.53 -0.18
Purchase of Property, Leasehold Improvements and Equipment		 -17 -66 -36 -58 -60 -33 -10 -2.95 -14 -0.36
Sale of Property, Leasehold Improvements and Equipment		 - - 0.34 0.31 0.23 0.77 0.15 0.03 9.65 0.18
Net Cash From Financing Activities		 38 -29 4.38 0.91 6.86 21 6.26 22 18 -9.05
Net Cash From Continuing Financing Activities		 38 -29 4.38 0.91 6.86 21 6.26 22 18 -9.05
Issuance of Debt		 45 - 4.38 4.85 9.21 29 19 34 43 31
Repayment of Debt		 -7.15 -29 0.00 -3.94 -2.35 -8.53 -13 -11 -8.38 -34
Other Financing Activities, Net		 - - - - - - - - - -5.77
Effect of Exchange Rate Changes		 -7.46 2.74 0.47 -3.65 1.09 -4.47 -5.25 -1.64 2.30 -2.24

Annual Balance Sheets for Microvast

This table presents Microvast's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 985 1,097 952
Cash and Due from Banks		 231 45 73
Restricted Cash		 71 44 37
Loans and Leases, Net of Allowance		 0.00 0.00 0.00
Premises and Equipment, Net		 348 633 490
Intangible Assets		 1.64 3.14 2.61
Other Assets		 333 373 350
Total Liabilities & Shareholders' Equity		 985 1,097 952
Total Liabilities		 372 533 564
Short-Term Debt		 131 254 231
Accrued Interest Payable		 67 149 99
Other Short-Term Payables		 54 0.00 0.01
Long-Term Debt		 73 87 189
Other Long-Term Liabilities		 47 42 45
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 613 564 388
Total Preferred & Common Equity		 613 564 388
Total Common Equity		 613 564 388
Common Stock		 1,416 1,481 1,513
Retained Earnings		 -791 -898 -1,093
Accumulated Other Comprehensive Income / (Loss)		 -18 -26 -38
Other Equity Adjustments		 6.03 6.03 6.03

Quarterly Balance Sheets for Microvast

This table presents Microvast's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 973 1,004 998 1,017 1,041 961 998
Cash and Due from Banks		 296 200 143 67 39 68 64
Restricted Cash		 83 60 28 22 45 35 40
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 299 456 510 561 628 508 516
Intangible Assets		 1.70 3.69 3.34 3.21 2.99 2.85 2.79
Other Assets		 294 284 314 363 325 348 375
Total Liabilities & Shareholders' Equity		 973 1,004 998 1,017 1,041 961 998
Total Liabilities		 357 398 418 449 495 506 512
Short-Term Debt		 116 131 123 159 187 188 188
Accrued Interest Payable		 80 94 117 122 138 143 105
Other Short-Term Payables		 36 53 53 54 41 41 43
Long-Term Debt		 82 73 75 75 86 91 121
Other Long-Term Liabilities		 43 47 50 38 42 43 55
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 616 606 580 567 546 455 486
Total Preferred & Common Equity		 616 604 578 565 546 455 486
Total Common Equity		 616 604 578 565 546 455 486
Common Stock		 1,398 1,434 1,452 1,468 1,493 1,506 1,512
Retained Earnings		 -757 -821 -847 -873 -922 -1,024 -1,011
Accumulated Other Comprehensive Income / (Loss)		 -31 -16 -34 -36 -31 -33 -22
Other Equity Adjustments		 6.03 6.03 6.03 6.03 6.03 6.03 6.03

Annual Metrics and Ratios for Microvast

This table displays calculated financial ratios and metrics derived from Microvast's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 33.44% 50.52% 23.62%
EBITDA Growth		 25.29% 40.35% -99.10%
EBIT Growth		 22.92% 33.58% -85.08%
NOPAT Growth		 23.40% 32.73% -83.70%
Net Income Growth		 23.38% 32.74% -83.68%
EPS Growth		 58.73% 34.62% -79.41%
Operating Cash Flow Growth		 -19.74% -39.64% 103.74%
Free Cash Flow Firm Growth		 93.47% -208.86% 76.12%
Invested Capital Growth		 -6.61% 10.88% -10.80%
Revenue Q/Q Growth		 -6.38% 13.39% 4.93%
EBITDA Q/Q Growth		 7.49% 13.94% -96.13%
EBIT Q/Q Growth		 7.16% 9.04% -70.50%
NOPAT Q/Q Growth		 7.76% 7.87% -70.56%
Net Income Q/Q Growth		 7.56% 7.88% -70.54%
EPS Q/Q Growth		 -4.00% 5.56% -60.53%
Operating Cash Flow Q/Q Growth		 31.72% -14.65% 134.15%
Free Cash Flow Firm Q/Q Growth		 -28.83% -139.63% 47.19%
Invested Capital Q/Q Growth		 0.31% 12.98% 1.59%
Profitability Metrics		 - - -
EBITDA Margin		 -67.90% -26.91% -43.34%
EBIT Margin		 -77.86% -34.36% -51.44%
Profit (Net Income) Margin		 -77.42% -34.59% -51.40%
Tax Burden Percent		 100.02% 100.01% 100.00%
Interest Burden Percent		 99.41% 100.67% 99.92%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -13.09% -8.65% -15.97%
ROIC Less NNEP Spread (ROIC-NNEP)		 -37.35% -20.36% -31.38%
Return on Net Nonoperating Assets (RNNOA)		 -11.25% -9.43% -25.09%
Return on Equity (ROE)		 -24.34% -18.08% -41.06%
Cash Return on Invested Capital (CROIC)		 -6.26% -18.97% -4.55%
Operating Return on Assets (OROA)		 -16.07% -10.15% -19.10%
Return on Assets (ROA)		 -15.98% -10.22% -19.08%
Return on Common Equity (ROCE)		 -24.34% -18.08% -41.06%
Return on Equity Simple (ROE_SIMPLE)		 -25.81% -18.86% -50.39%
Net Operating Profit after Tax (NOPAT)		 -111 -74 -137
NOPAT Margin		 -54.18% -24.21% -35.98%
Net Nonoperating Expense Percent (NNEP)		 24.26% 11.72% 15.41%
SG&A Expenses to Revenue		 32.36% 22.31% 16.74%
Operating Expenses to Revenue		 177.86% 134.36% 151.44%
Earnings before Interest and Taxes (EBIT)		 -159 -106 -196
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -139 -83 -165
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.77 0.79 1.73
Price to Tangible Book Value (P/TBV)		 0.77 0.79 1.74
Price to Revenue (P/Rev)		 2.32 1.44 1.76
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.46 0.77 1.21
Enterprise Value to Revenue (EV/Rev)		 1.83 2.26 2.58
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 348.46
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.33 0.61 1.08
Long-Term Debt to Equity		 0.12 0.15 0.49
Financial Leverage		 0.30 0.46 0.80
Leverage Ratio		 1.52 1.77 2.15
Compound Leverage Factor		 1.51 1.78 2.15
Debt to Total Capital		 24.94% 37.70% 51.98%
Short-Term Debt to Total Capital		 16.02% 28.10% 28.60%
Long-Term Debt to Total Capital		 8.92% 9.60% 23.38%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 75.06% 62.30% 48.02%
Debt to EBITDA		 -1.47 -4.13 -2.55
Net Debt to EBITDA		 0.71 -3.06 -1.88
Long-Term Debt to EBITDA		 -0.53 -1.05 -1.15
Debt to NOPAT		 -1.84 -4.58 -3.07
Net Debt to NOPAT		 0.89 -3.40 -2.27
Long-Term Debt to NOPAT		 -0.66 -1.17 -1.38
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -53 -163 -39
Operating Cash Flow to CapEx		 -35.74% -40.67% 15.88%
Free Cash Flow to Firm to Interest Expense		 -15.92 -62.17 -4.02
Operating Cash Flow to Interest Expense		 -16.23 -28.65 0.29
Operating Cash Flow Less CapEx to Interest Expense		 -61.63 -99.10 -1.53
Efficiency Ratios		 - - -
Asset Turnover		 0.21 0.30 0.37
Fixed Asset Turnover		 0.66 0.63 0.68
Capital & Investment Metrics		 - - -
Invested Capital		 817 906 808
Invested Capital Turnover		 0.24 0.36 0.44
Increase / (Decrease) in Invested Capital		 -58 89 -98
Enterprise Value (EV)		 375 696 981
Market Capitalization		 473 443 670
Book Value per Share		 $1.98 $1.78 $1.20
Tangible Book Value per Share		 $1.98 $1.77 $1.19
Total Capital		 817 906 808
Total Debt		 204 341 420
Total Long-Term Debt		 73 87 189
Net Debt		 -98 253 310
Capital Expenditures (CapEx)		 151 185 18
Net Nonoperating Expense (NNE)		 47 32 59
Net Nonoperating Obligations (NNO)		 204 341 420
Total Depreciation and Amortization (D&A)		 20 23 31
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 ($0.52) ($0.34) ($0.61)
Adjusted Weighted Average Basic Shares Outstanding		 303.28M 310.91M 318.46M
Adjusted Diluted Earnings per Share		 ($0.52) ($0.34) ($0.61)
Adjusted Weighted Average Diluted Shares Outstanding		 303.28M 310.91M 318.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 309.41M 317.21M 325.21M
Normalized Net Operating Profit after Tax (NOPAT)		 -111 -76 -17
Normalized NOPAT Margin		 -54.47% -24.56% -4.60%
Pre Tax Income Margin		 -77.40% -34.59% -51.40%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -47.88 -40.22 -20.14
NOPAT to Interest Expense		 -33.32 -28.34 -14.09
EBIT Less CapEx to Interest Expense		 -93.29 -110.67 -21.97
NOPAT Less CapEx to Interest Expense		 -78.72 -98.79 -15.91
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Microvast

This table displays calculated financial ratios and metrics derived from Microvast's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 16.35% -17.54% 32.36% 18.84% 107.19% 58.00% 66.49% 7.69% 21.29% 17.27%
EBITDA Growth		 71.59% 27.36% 36.14% 46.17% 33.18% 45.76% 29.88% -347.69% 199.24% -361.61%
EBIT Growth		 68.59% 26.17% 32.45% 40.98% 28.38% 31.04% 16.05% -289.43% 150.62% -245.56%
NOPAT Growth		 68.60% 28.32% 32.45% 40.98% 28.38% 26.98% 16.05% -289.43% 172.31% -234.91%
Net Income Growth		 68.63% 27.75% 32.45% 40.98% 28.38% 27.03% 16.05% -289.43% 150.62% -234.77%
EPS Growth		 75.51% -25.00% 33.33% 46.67% 33.33% 20.00% 20.00% -300.00% 137.50% -200.00%
Operating Cash Flow Growth		 151.31% 122.89% 55.18% 22.73% -693.97% -206.13% 118.19% 100.37% 81.50% 223.18%
Free Cash Flow Firm Growth		 107.71% 104.91% 102.80% 109.45% -110.60% -409.73% -263.55% -148.60% 446.47% 137.88%
Invested Capital Growth		 -8.84% -6.61% -4.42% -8.87% -1.56% 10.88% 1.24% -5.56% -0.79% -10.80%
Revenue Q/Q Growth		 -39.45% 69.23% -28.71% 58.65% 5.56% 29.06% -22.97% 2.62% 18.89% 24.78%
EBITDA Q/Q Growth		 18.86% 5.69% 17.94% 14.28% -1.91% 23.45% -4.52% -447.29% 129.37% -456.06%
EBIT Q/Q Growth		 17.29% 5.30% 14.56% 11.81% -1.30% 8.80% -2.96% -309.09% 116.76% -722.62%
NOPAT Q/Q Growth		 17.29% 7.88% 12.16% 11.81% -0.36% 6.08% -0.99% -309.09% 124.13% -535.01%
Net Income Q/Q Growth		 17.29% 7.79% 12.25% 11.81% -0.36% 6.04% -0.95% -309.09% 116.89% -721.45%
EPS Q/Q Growth		 20.00% 16.67% 0.00% 20.00% 0.00% 0.00% 0.00% -300.00% 112.00% -900.00%
Operating Cash Flow Q/Q Growth		 112.79% -5.53% -339.25% -167.26% 1.68% 83.12% 141.01% -94.53% -4,990.99% 212.38%
Free Cash Flow Firm Q/Q Growth		 108.80% -35.84% -51.01% 241.85% -109.87% -1,774.75% 56.45% -1.59% 156.32% 104.95%
Invested Capital Q/Q Growth		 -4.53% 0.31% -0.85% -4.02% 3.13% 12.98% -4.95% -10.47% 5.03% 1.59%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 -81.69% -45.52% -51.10% -27.61% -26.35% -15.63% -21.52% -114.78% 21.56% -61.51%
EBIT Margin		 -94.40% -52.83% -61.74% -34.32% -32.63% -23.06% -31.13% -124.11% 13.62% -67.95%
Profit (Net Income) Margin		 -94.40% -51.44% -61.74% -34.32% -32.63% -23.76% -31.13% -124.11% 13.62% -67.82%
Tax Burden Percent		 100.00% 100.10% 100.00% 100.00% 100.00% 100.04% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 97.27% 100.00% 100.00% 100.00% 102.99% 100.00% 100.00% 100.00% 99.81%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -16.90% -8.69% -11.36% -6.77% -7.67% -5.94% -9.08% -39.70% 6.18% -21.07%
ROIC Less NNEP Spread (ROIC-NNEP)		 -22.75% -13.87% -15.86% -10.72% -11.30% -8.65% -12.20% -52.49% 6.18% -27.56%
Return on Net Nonoperating Assets (RNNOA)		 -6.40% -4.18% -4.94% -3.44% -4.13% -4.00% -5.06% -24.17% 3.19% -22.04%
Return on Equity (ROE)		 -23.29% -12.87% -16.30% -10.22% -11.80% -9.94% -14.14% -63.87% 9.37% -43.11%
Cash Return on Invested Capital (CROIC)		 -4.81% -6.26% -7.64% -1.53% -8.44% -18.97% -9.97% -10.69% -9.25% -4.55%
Operating Return on Assets (OROA)		 -20.99% -10.90% -13.43% -8.01% -8.90% -6.81% -10.34% -43.75% 4.90% -25.22%
Return on Assets (ROA)		 -20.99% -10.62% -13.43% -8.01% -8.90% -7.02% -10.34% -43.75% 4.90% -25.18%
Return on Common Equity (ROCE)		 -23.29% -12.87% -16.28% -10.20% -11.78% -9.94% -14.11% -63.75% 9.35% -43.11%
Return on Equity Simple (ROE_SIMPLE)		 -27.79% 0.00% -23.85% -21.79% -20.43% 0.00% -18.62% -38.93% -23.58% 0.00%
Net Operating Profit after Tax (NOPAT)		 -26 -24 -21 -18 -18 -17 -17 -71 13 -58
NOPAT Margin		 -66.08% -35.97% -43.22% -24.02% -22.84% -16.62% -21.79% -86.88% 13.62% -47.47%
Net Nonoperating Expense Percent (NNEP)		 5.85% 5.18% 4.51% 3.95% 3.63% 2.71% 3.12% 12.79% 0.00% 6.49%
SG&A Expenses to Revenue		 43.96% 24.03% 33.09% 20.27% 24.03% 17.48% 21.42% 18.49% 16.09% 12.99%
Operating Expenses to Revenue		 194.40% 152.83% 161.74% 134.32% 132.63% 123.06% 131.13% 224.11% 86.38% 167.95%
Earnings before Interest and Taxes (EBIT)		 -37 -35 -30 -26 -26 -24 -25 -102 13 -82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -32 -30 -24 -21 -21 -16 -17 -94 21 -75
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.89 0.77 0.64 0.86 1.06 0.79 0.49 0.32 0.17 1.73
Price to Tangible Book Value (P/TBV)		 0.89 0.77 0.64 0.86 1.06 0.79 0.49 0.32 0.17 1.74
Price to Revenue (P/Rev)		 2.51 2.32 1.76 2.15 2.20 1.44 0.78 0.42 0.22 1.76
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.45 0.46 0.41 0.67 0.93 0.77 0.55 0.44 0.36 1.21
Enterprise Value to Revenue (EV/Rev)		 1.68 1.83 1.51 2.28 2.75 2.26 1.34 0.93 0.79 2.58
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 348.46
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.32 0.33 0.34 0.34 0.41 0.61 0.50 0.61 0.64 1.08
Long-Term Debt to Equity		 0.13 0.12 0.12 0.13 0.13 0.15 0.16 0.20 0.25 0.49
Financial Leverage		 0.28 0.30 0.31 0.32 0.37 0.46 0.41 0.46 0.52 0.80
Leverage Ratio		 1.47 1.52 1.59 1.60 1.68 1.77 1.77 1.89 1.91 2.15
Compound Leverage Factor		 1.47 1.48 1.59 1.60 1.68 1.82 1.77 1.89 1.91 2.15
Debt to Total Capital		 24.36% 24.94% 25.18% 25.41% 29.22% 37.70% 33.38% 38.01% 38.87% 51.98%
Short-Term Debt to Total Capital		 14.31% 16.02% 16.16% 15.77% 19.89% 28.10% 22.87% 25.66% 23.65% 28.60%
Long-Term Debt to Total Capital		 10.05% 8.92% 9.02% 9.64% 9.32% 9.60% 10.51% 12.35% 15.21% 23.38%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.27% 0.26% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 75.64% 75.06% 74.55% 74.33% 70.54% 62.30% 66.62% 61.99% 61.13% 48.02%
Debt to EBITDA		 -1.32 -1.47 -1.63 -1.85 -2.44 -4.13 -3.63 -1.88 -3.68 -2.55
Net Debt to EBITDA		 1.20 0.71 0.45 -0.25 -1.51 -3.06 -2.51 -1.19 -2.44 -1.88
Long-Term Debt to EBITDA		 -0.55 -0.53 -0.58 -0.70 -0.78 -1.05 -1.14 -0.61 -1.44 -1.15
Debt to NOPAT		 -1.65 -1.84 -2.02 -2.24 -2.90 -4.58 -3.85 -2.25 -3.85 -3.07
Net Debt to NOPAT		 1.51 0.89 0.56 -0.31 -1.79 -3.40 -2.66 -1.42 -2.56 -2.27
Long-Term Debt to NOPAT		 -0.68 -0.66 -0.72 -0.85 -0.92 -1.17 -1.21 -0.73 -1.51 -1.38
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.17% 0.17% 0.17% 0.00% 0.19% 0.20% 0.19% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 53 34 17 57 -5.66 -106 -27 -28 20 40
Operating Cash Flow to CapEx		 29.39% 7.05% -31.38% -51.99% -49.14% -15.27% 20.13% 3.81% -119.85% 3,389.44%
Free Cash Flow to Firm to Interest Expense		 68.98 39.92 36.56 117.79 -11.53 -89.08 -15.85 -13.31 4.57 25.19
Operating Cash Flow to Interest Expense		 6.38 5.44 -24.33 -61.28 -59.76 -4.16 1.17 0.05 -1.27 3.83
Operating Cash Flow Less CapEx to Interest Expense		 -15.33 -71.67 -101.85 -179.14 -181.37 -31.40 -4.65 -1.34 -2.32 3.71
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.22 0.21 0.22 0.23 0.27 0.30 0.33 0.35 0.36 0.37
Fixed Asset Turnover		 0.82 0.66 0.59 0.56 0.63 0.63 0.63 0.68 0.67 0.68
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 814 817 810 777 802 906 820 734 795 808
Invested Capital Turnover		 0.26 0.24 0.26 0.28 0.34 0.36 0.42 0.46 0.45 0.44
Increase / (Decrease) in Invested Capital		 -79 -58 -37 -76 -13 89 10 -43 -6.36 -98
Enterprise Value (EV)		 367 375 329 524 745 696 454 321 286 981
Market Capitalization		 548 473 384 495 598 443 265 145 81 670
Book Value per Share		 $2.04 $1.98 $1.95 $1.87 $1.79 $1.78 $1.73 $1.43 $1.50 $1.20
Tangible Book Value per Share		 $2.03 $1.98 $1.94 $1.86 $1.78 $1.77 $1.72 $1.43 $1.49 $1.19
Total Capital		 814 817 810 777 802 906 820 734 795 808
Total Debt		 198 204 204 197 234 341 274 279 309 420
Total Long-Term Debt		 82 73 73 75 75 87 86 91 121 189
Net Debt		 -181 -98 -57 27 145 253 190 176 205 310
Capital Expenditures (CapEx)		 17 66 36 57 60 32 10 2.92 4.53 0.18
Net Nonoperating Expense (NNE)		 11 10 8.87 7.82 7.85 7.38 7.45 30 0.00 25
Net Nonoperating Obligations (NNO)		 198 204 204 197 234 341 274 279 309 420
Total Depreciation and Amortization (D&A)		 4.92 4.78 5.10 5.10 5.04 7.69 7.66 7.64 7.72 7.81
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.12) ($0.10) ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.04 ($0.25)
Adjusted Weighted Average Basic Shares Outstanding		 305.98M 303.28M 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 320.55M 318.46M
Adjusted Diluted Earnings per Share		 ($0.12) ($0.10) ($0.10) ($0.08) ($0.08) ($0.08) ($0.08) ($0.32) $0.03 ($0.24)
Adjusted Weighted Average Diluted Shares Outstanding		 305.98M 303.28M 307.71M 307.74M 313.11M 310.91M 315.37M 315.51M 367.03M 318.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 309.29M 309.41M 309.43M 316.31M 316.53M 317.21M 317.20M 323.82M 323.82M 325.21M
Normalized Net Operating Profit after Tax (NOPAT)		 -26 -23 -21 -18 -18 -17 -18 -9.31 1.41 4.50
Normalized NOPAT Margin		 -67.83% -35.69% -44.51% -24.34% -22.93% -16.76% -22.18% -11.38% 1.45% 3.71%
Pre Tax Income Margin		 -94.40% -51.39% -61.74% -34.32% -32.63% -23.75% -31.13% -124.11% 13.62% -67.82%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 -47.21 -40.34 -64.42 -53.55 -53.30 -20.04 -14.33 -48.50 3.09 -51.71
NOPAT to Interest Expense		 -33.05 -27.47 -45.10 -37.48 -37.31 -14.45 -10.03 -33.95 3.09 -36.13
EBIT Less CapEx to Interest Expense		 -68.93 -117.44 -141.95 -171.41 -174.92 -47.28 -20.16 -49.89 2.03 -51.82
NOPAT Less CapEx to Interest Expense		 -54.76 -104.57 -122.62 -155.35 -158.93 -41.69 -15.86 -35.34 2.03 -36.24
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Microvast's Financials

When does Microvast's fiscal year end?

According to the most recent income statement we have on file, Microvast's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Microvast's net income changed over the last 2 years?

Microvast's net income appears to be on an upward trend, with a most recent value of -$195.46 million in 2024, rising from -$158.20 million in 2022. The previous period was -$106.41 million in 2023.

How has Microvast revenue changed over the last 2 years?

Over the last 2 years, Microvast's total revenue changed from $204.35 million in 2022 to $380.24 million in 2024, a change of 86.1%.

How much debt does Microvast have?

Microvast's total liabilities were at $563.97 million at the end of 2024, a 5.9% increase from 2023, and a 51.6% increase since 2022.

How much cash does Microvast have?

In the past 2 years, Microvast's cash and equivalents has ranged from $44.54 million in 2023 to $231.42 million in 2022, and is currently $73.01 million as of their latest financial filing in 2024.

How has Microvast's book value per share changed over the last 2 years?

Over the last 2 years, Microvast's book value per share changed from 1.98 in 2022 to 1.20 in 2024, a change of -39.6%.


Related Companies

This page (NASDAQ:MVSTW) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored